Fermented milk supplemented with probiotics and prebiotics can effectively alter the intestinal microbiota and immunity of host animals

Journal of Dairy Science

Volumn 95, Issue 9, 2012, Pages 4813-4822

  Wang, S ^a,b   Zhu, H ^b   Lu, C ^b   Kang, Z ^b   Luo, Y ^a   Feng, L ^b   Lu, X ^b  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

^b Shijiazhuang Junlebao Dairy Co Ltd   (China)

Author keywords

Fermented milk; Immune response; Intestinal microbiota; Synbiotic

Indexed keywords

PROBIOTIC AGENT; YOGHURT;

ADULT; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIFIDOBACTERIUM; CELLULAR IMMUNITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAIRY PRODUCT; DIET SUPPLEMENTATION; FECES; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNITY; INTESTINE; LACTOBACILLUS ACIDOPHILUS; MALE; METABOLISM; METAGENOME; MICROBIOLOGY; MOUSE; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANIMALS; BIFIDOBACTERIUM; CULTURED MILK PRODUCTS; DIETARY SUPPLEMENTS; FECES; FEMALE; HUMANS; IMMUNITY; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INTESTINES; LACTOBACILLUS ACIDOPHILUS; MALE; METAGENOME; MICE; MICE, INBRED BALB C; PROBIOTICS; YOGURT;

EID: 84865339342     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2012-5426     Document Type: Article

References (46)

1. Andreasen A.S., Larsen N., Pedersen-Skovsgaard T., Berg R.M., Moller K., Svendsen K.D., Jakobsen M., Pedersen B.K. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br. J. Nutr. 2010, 104:1831-1838.
2. Bernet-Camard M.F., Liévin V., Brassart D., Neeser J.R., Servin A.L., Hudault S. The human Lactobacillus acidophilus strain La1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol. 1997, 63:2747-2753.
3. Candela M., Bergmann S., Vici M., Vitali B., Turroni S., Eikmanns B.J., Hammerschmidt S., Brigidi P. Binding of human plasminogen to Bifidobacterium. J. Bacteriol. 2007, 189:5929-5936.
4. Davis C.D., Milner J.A. Gastrointestinal microflora, food components and colon cancer prevention. J. Nutr. Biochem. 2009, 20:743-752.
5. Delcenserie V., Martel D., Lamoureux M., Amiot J., Boutin Y., Roy D. Immunomodulatory effects of probiotics in the intestinal tract. Curr. Issues Mol. Biol. 2008, 10:37-54.
6. Galdeano C.M., de Leblanc Ade M., Carmuega E., Weill R., Perdigón G. Mechanisms involved in the immunostimulation by probiotic fermented milk. J. Dairy Res. 2009, 76:446-454.
7. Garrido D., Suau A., Pochart P., Cruchet S., Gotteland M. Modulation of the fecal microbiota by the intake of a Lactobacillus johnsonii La1-containing product in human volunteers. FEMS Microbiol. Lett. 2005, 248:249-256.
8. Gill H.S. Stimulation of the immune system by lactic cultures. Int. Dairy J. 1998, 8:535-544.
9. Gotteland M., Cruchet S., Verbeke S. Eff{ligature}ect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indomethacin in humans. Aliment. Pharmacol. Ther. 2001, 15:11-17.
10. Haller D., Blum S., Bode C., Hammes W.P., Schiff{ligature}rin E.J. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: Evidence of NK cells as primary targets. Infect. Immun. 2000, 68:752-759.
11. Kalliomäki M., Isolauri E. Role of intestinal flora in the development of allergy. Curr. Opin. Allergy Clin. Immunol. 2003, 3:15-20.
12. Kanauchi O., Mitsuyama K., Araki Y., Andoh A. Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr. Pharm. Des. 2003, 9:333-346.
13. Khurana H., Kanawjia S.K. Recent trends in development of fermented milks. Curr. Nutr. Food Sci. 2007, 3:91-108.
14. Knight D.J., Gardiner D., Banks A., Snape S.E., Weston V.C., Bengmark S., Girling K.J. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: A randomised, double-blind, placebo-controlled trial. Intensive Care Med. 2009, 35:854-861.
15. Kukkonen K., Savilahti E., Haahtela T., Juntunen-Backman K., Korpela R., Poussa T., Tuure T., Kuitunen M. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: Randomized, double-blind, placebo-controlled trial. Pediatrics 2008, 122:8-12.
16. ® modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly. Age (Dordr.) 2012, 34:133-143.
17. Larsen N., Vogensen F.K., Gobel R., Michaelsen K.F., Abu Al-Soud W., Sorensen S.J., Hansen L.H., Jakobsen M. Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis ssp. lactis Bi-07. FEMS Microbiol. Ecol. 2011, 75:482-496.
18. Liu X.-Y., Hu Y.-X., Hu Y.-M., Ma Z., Yin J. Experimental observation on the functions of extracts of stachyose and spine date seed in enhancing immunity and moving bowels in mice. China Trop. Med. 2009, 9:571-576.
19. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., Nalin R., Jarrin C., Chardon P., Marteau P., Roca J., Dore J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55:205-211.
20. Norms on Health-Care Food Examination and Technology Assessment 2003, Ministry of Health of the People's Republic of China, Ministry of Health of the People's Republic of China, Beijing.
21. Mitsuoka T. A Color Atlas of Anaerobic Bacteria 1980, Tokyo University Press, Tokyo. 1st ed.
22. Mohan R., Koebnick C., Schildt J., Mueller M., Radke M., Blaut M. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr. Res. 2008, 64:418-422.
23. Mohan R., Koebnick C., Schildt J., Schmidt S., Mueller M., Possner M., Radke M., Blaut M. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: A double-blind, placebo-controlled, randomized study. J. Clin. Microbiol. 2006, 44:4025-4031.
24. Moore W.E., Moore L.H. Intestinal floras of populations that have a high risk of colon cancer. Appl. Environ. Microbiol. 1995, 61:3202-3207.
25. Ooi L.G., Ahmad R., Yuen K.H., Liong M.T. Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters. J. Dairy Sci. 2010, 93:5048-5058.
26. Ooi L.G., Bhat R., Rosma A., Yuen K.H., Liong M.T. A synbiotic containing Lactobacillus gasseri [corrected] CHO-220 and inulin improves irregularity of red blood cells. J. Dairy Sci. 2010, 93:4535-4544.
27. Ouwehand A.C., Tiihonen K., Saarinen M., Putaala H., Rautonen N. Influence of a combination of Lactobacillus acidophilus NCFM and lactitol on healthy elderly: Intestinal and immune parameters. Br. J. Nutr. 2009, 101:367-375.
28. Penders J., Thijs C., van den Brandt P.A., Kummeling I., Snijders B., Stelma F., Adam H., van Ree R., Stobberingh E.E. Gut microbiota composition and development of atopic manifestations in infancy: The KOALA birth cohort study. Gut 2007, 56:661-667.
29. Qin J., Lu Y.-B., Liao Q., Tian J., Wang Y.-E., Fan B.-L. Effect of amino acid complex (oral liquid) on enhancing immune function in mice. J. Public Health Prev. Med. 2010, 21:28-30.
30. Quigley E.M.M. Prebiotics and probiotics: Modifying and mining the microbiota. Pharmacol. Res. 2010, 61:213-218.
31. Quigley E.M.M. Probiotics in gastrointestinal disorders. Hosp. Pract. (Minneapolis) 2010, 38:122-129.
32. Quigley E.M.M. Probiotics in functional bowel disorders getting it right. J. Clin. Gastroenterol. 2011, 45:481-482.
33. Rafter J., Bennett M., Caderni G., Clune Y., Hughes R., Karlsson P.C., Klinder A., O'Riordan M., O'Sullivan G.C., Pool-Zobel B., Rechkemmer G., Roller M., Rowland I., Salvadori M., Thijs H., Van Loo J., Watzl B., Collins J.K. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 2007, 85:488-496.
34. Ringel-Kulka T., Palsson O.S., Maier D., Carroll I., Galanko J.A., Leyer G., Ringel Y. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: A double-blind study. J. Clin. Gastroenterol. 2011, 45:518-525.
35. Roberfroid M. Prebiotics: The concept revisited. J. Nutr. 2007, 137(Suppl. 2):830S-837S.
36. Ruemmele F.M., Bier D., Marteau P., Rechkemmer G., Bourdet-Sicard R., Walker W.A., Goulet O. Clinical evidence for immunomodulatory effects of probiotic bacteria. J. Pediatr. Gastroenterol. Nutr. 2009, 48:126-141.
37. Salva S., Villena J., Alvarez S. Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: Impact on intestinal and respiratory infections. Int. J. Food Microbiol. 2010, 141:82-89.
38. Sanders M.E., Klaenhammer T.R. Invited review: The scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J. Dairy Sci. 2001, 84:319-331.
39. Sekirov I., Russell S.L., Antunes L.C.M., Finlay B.B. Gut microbiota in health and disease. Physiol. Rev. 2010, 90:859-904.
40. Tannock G.W., Munro K., Harmsen H.J., Welling G.W., Smart J., Gopal P.K. Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20. Appl. Environ. Microbiol. 2000, 66:2578-2588.
41. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
42. Wallace T.C., Guarner F., Madsen K., Cabana M.D., Gilson G., Hentges E., Sanders M.E. Human gut microbiota and its relationship to health and disease. Nutr. Rev. 2011, 69:392-403.
43. Weiss G., Rasmussen S., Zeuthen L.H., Nielsen B.N., Jarmer H., Jespersen L., Frokiaer H. Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism. Immunology 2010, 131:268-281.
44. Wen L., Ley R.E., Volchkov P.Y., Stranges P.B., Avanesyan L., Stonebraker A.C., Hu C., Wong F.S., Szot G.L., Bluestone J.A., Gordon J.I., Chervonsky A.V. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008, 455:1109-1113.
45. Yang H.-Y., Liu A.-P., Jiang J.-L., Zhang M., Ren F.-Z. Research on in vivo immunostimulation function of Bifidobacterium strain BBMN01. Food Sci. 2008, 29:369-372.
46. Yen C.H., Tseng Y.H., Kuo Y.W., Lee M.C., Chen H.L. Long-term supplementation of isomalto-oligosaccharides improved colonic microflora profile, bowel function, and blood cholesterol levels in constipated elderly people-A placebo-controlled, diet-controlled trial. Nutrition 2011, 27:445-450.